Company Chairman and CEO Alex Lukianov told the analysts on October 22, while the overall spine market will continue to grow in excess of 10%, NuVasive expects to generate revenue growth in the 30% to 35% range in 2010.
Orthopedics This Week... http://ow.ly/x2y6...
Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
